Chronic Lymphocytic Leukemia: Insights Into the Pharmacist Role in Therapy Management

Program Description

Pharmacists are central to the management of therapies for patients with chronic lymphocytic leukemia (CLL) and can assist in patient education, adherence strategies, and management of adverse effects. This podcast will feature a discussion of common adverse effects associated with therapies for CLL and strategies for their management. An expert will share best practices and counseling points pharmacists should include when selecting and initiating therapy in a patient with CLL.

Target audience: Health-system and oncology pharmacists

Type of activity: Knowledge
Release date: June 30, 2022
Expiration date: June 30, 2023

Time to complete activity: 0.5 hour
Fee: Free

Educational Objectives

At the completion of this activity, participants will be able to:

• Outline an onboarding plan to effectively prevent, monitor, and educate patients about adverse effects of oral therapies for chronic lymphocytic leukemia treatment

Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 0.5 contact hour (0.05 CEU) under the ACPE universal activity number 0290-0000-22-320-H01-P. The activity is available for CE credit through June 30, 2023.

Instructions for Completing the Activity and Receiving CPE Credit

To receive CPE credit, participants must complete the pretest, listen to the podcast in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.

Disclosures

The following contributors have no relevant financial relationships with commercial interests to disclose:

Faculty

Katherine Tobon, PharmD, BCOP

Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh; Meg Taylor, PharmD, CPP; Kylie Ferrentino; Susan Pordon; Brianna Winters; and Chloe Taccetta

Anonymous peer reviewers were used as part of content validation and conflict resolution. The peer reviewers have no relevant financial relationships with commercial interests to disclose.

Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.

For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms